Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Nat Protoc. 2011 Aug 4;6(9):1251-73. doi: 10.1038/nprot.2011.374.
The generation of induced pluripotent stem cells (iPSCs) devoid of permanently integrated reprogramming factor genes is essential to reduce differentiation biases and artifactual phenotypes. We describe a protocol for the generation of human iPSCs using a single polycistronic lentiviral vector (pLM-fSV2A) coexpressing OCT4, SOX2, KLF4 and c-MYC; this is flanked by two loxP sites in its long terminal repeats (LTRs). Human iPSC lines are established with an efficiency of up to 1% and screened to select single or low vector copy lines. To deal with potential insertional mutagenesis, the vector integrations are then mapped to the human genome. Finally, the vector is excised by transient expression of Cre recombinase (coexpressed with mCherry) through an integrase-deficient lentiviral vector. Vector-excised iPSC lines maintain all characteristics of pluripotency. This protocol can be used to efficiently derive transgene-free iPSCs from many different starting cell types in approximately 12-14 weeks.
生成无永久性整合重编程因子基因的诱导多能干细胞(iPSCs)对于降低分化偏差和人为表型至关重要。我们描述了一种使用单个多顺反子慢病毒载体(pLM-fSV2A)生成人 iPSCs 的方案,该载体共表达 OCT4、SOX2、KLF4 和 c-MYC;其长末端重复序列(LTR)两侧有两个 loxP 位点。人 iPSC 系的建立效率高达 1%,并进行筛选以选择单拷贝或低拷贝载体的系。为了应对潜在的插入诱变,然后将载体整合映射到人类基因组上。最后,通过整合酶缺陷型慢病毒载体瞬时表达 Cre 重组酶(与 mCherry 共表达)切除载体。切除载体的 iPSC 系保持多能性的所有特征。该方案可用于在大约 12-14 周内从许多不同的起始细胞类型高效获得无转基因的 iPSCs。